Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Matthew LaCasse & Joanna Quigley. (2022) Naltrexone for adolescent opioid use disorder: a bridge in the treatment gap?. Journal of Substance Use 27:3, pages 239-243.
Read now
Read now
Erin Kelty, David Joyce & Gary Hulse. (2019) A retrospective cohort study of mortality rates in patients with an opioid use disorder treated with implant naltrexone, oral methadone or sublingual buprenorphine. The American Journal of Drug and Alcohol Abuse 45:3, pages 285-291.
Read now
Read now
Articles from other publishers (12)
Thomas SantoJrJr, Brodie Clark, Matt Hickman, Jason Grebely, Gabrielle Campbell, Luis Sordo, Aileen Chen, Lucy Thi Tran, Chrianna Bharat, Prianka Padmanathan, Grainne Cousins, Julie Dupouy, Erin Kelty, Roberto Muga, Bohdan Nosyk, Jeong Min, Raimondo Pavarin, Michael Farrell & Louisa Degenhardt. (2021) Association of Opioid Agonist Treatment With All-Cause Mortality and Specific Causes of Death Among People With Opioid Dependence. JAMA Psychiatry 78:9, pages 979.
Crossref
Crossref
Anees Bahji, Breagh Cheng, Samantha Gray & Heather Stuart. (2020) Mortality Among People With Opioid Use Disorder: A Systematic Review and Meta-analysis. Journal of Addiction Medicine 14:4, pages e118-e132.
Crossref
Crossref
Lindsay A Pearce, Jeong Eun Min, Micah Piske, Haoxuan Zhou, Fahmida Homayra, Amanda Slaunwhite, Mike Irvine, Gina McGowan & Bohdan Nosyk. (2020) Opioid agonist treatment and risk of mortality during opioid overdose public health emergency: population based retrospective cohort study. BMJ, pages m772.
Crossref
Crossref
Shao-Cheng Wang & Brion Maher. (2019) Substance Use Disorder, Intravenous Injection, and HIV Infection: A Review. Cell Transplantation 28:12, pages 1465-1471.
Crossref
Crossref
Jun Ma, Yan-Ping Bao, Ru-Jia Wang, Meng-Fan Su, Mo-Xuan Liu, Jin-Qiao Li, Louisa Degenhardt, Michael Farrell, Frederic C. Blow, Mark Ilgen, Jie Shi & Lin Lu. (2018) Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis. Molecular Psychiatry 24:12, pages 1868-1883.
Crossref
Crossref
A. Bahji, B. Cheng, S. Gray & H. Stuart. (2019) Reduction in mortality risk with opioid agonist therapy: a systematic review and meta‐analysis. Acta Psychiatrica Scandinavica 140:4, pages 313-339.
Crossref
Crossref
Sarah Larney, Linda Gowing, Richard P. Mattick, Michael Farrell, Wayne Hall & Louisa Degenhardt. (2014) A systematic review and meta-analysis of naltrexone implants for the treatment of opioid dependence. Drug and Alcohol Review 33:2, pages 115-128.
Crossref
Crossref
Bradley M MathersLouisa DegenhardtChiara BucelloJames LemonLucas WiessingMathew Hickman. (2013) Mortality among people who inject drugs: a systematic review and meta-analysis. Bulletin of the World Health Organization 91:2, pages 102-123.
Crossref
Crossref
Erin Kelty & Gary Hulse. (2012) Examination of mortality rates in a retrospective cohort of patients treated with oral or implant naltrexone for problematic opiate use. Addiction 107:10, pages 1817-1824.
Crossref
Crossref
Wim van den Brink. 2012. Essential Evidence-Based Psychopharmacology. Essential Evidence-Based Psychopharmacology
235
261
.
A. Naderi-Heiden, A. Gleiss, C. Bäcker, D. Bieber, H. Nassan-Agha, S. Kasper & R. Frey. (2020) Mortality and employment after in-patient opiate detoxification. European Psychiatry 27:4, pages 294-300.
Crossref
Crossref
Albert Stuart Reece. (2012) Epidemiologic and Molecular Pathophysiology of Chronic Opioid Dependence and the Place of Naltrexone Extended-Release Formulations in its Clinical Management. Substance Abuse: Research and Treatment 6, pages SART.S9031.
Crossref
Crossref